Rainmed Medical : Revenue grew 41.3% as gross margin expanded and losses narrowed
Moins d'1 minute de lecture
H1 revenue rose 41.3% YoY and gross margin reached 63.2%, while shareholder-attributable loss narrowed to RMB22.0m. Growth was led by caFFR transducers, with cutting balloon sales commencing amid a challenging, tighter-regulation market.
Original document: Rainmed Medical Limited [2297] Earnings Release — Aug. 31 2026
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
© AI-generated summary is provided by Quartr